International Newsletter : Tax Law
Jérémie Mancel-Cottrel
The French IP Box: A growing incentive for locating IP development and exploitation in France
As businesses increasingly seek to optimise the location of their R&D and intellectual property activities, France’s IP Box regime has become an important component of the country’s innovation tax framework.
Several years into its life, the IP Box which was a niche option is increasingly used as a tax planning tool by innovative businesses in France. Companies with meaningful patent portfolios, software assets or R&D operations now take this option into account when managing their French IP holding structures, and both tax authorities and advisors now have a better understanding of how it operates in practice. Numerator expenses benefit from a 30% uplift, capped so the ratio never exceeds 100%, reserving the benefit for genuine value-creating activity rather than mere IP ownership.
Key benefits
For groups considering where to locate the development and exploitation of their industrial and intellectual property, the French IP Box is a genuine incentive. A 10% effective rate on qualifying IP income compares favourably with the standard corporate tax rate, and the regime is open across sectors, without restriction by company size. It can be combined with the French R&D tax credit (crédit d’impôt recherche), one of the most generous in Europe, so the same R&D spend can generate both an immediate tax credit and, later, a reduced tax rate on the resulting IP income. The election is made asset by asset (or by product family), giving businesses flexibility, and losses on an eligible asset can be offset against ordinary taxable profits, limiting downside risk.
Points requiring particular attention
The regime’s apparent simplicity conceals real technical complexity. etermining eligible net income requires tracing, for each asset, the R&D expenses directly linked to its creation, acquisition and development since the year of election, calling for granular, well-documented cost accounting. The nexus ratio must be recalculated every year on a cumulative basis, and its composition, particularly the split between in-house or unrelated-party R&D and related-party or acquired IP, can significantly affect the benefit obtained.
This is especially sensitive within groups. Where the IP holding entity does not itself perform the underlying R&D, or sub-licences flow between related entities, the tracking exercise becomes more demanding and interacts closely with transfer pricing policy. Cross-border groups should also consider how the French election interacts with IP regimes and transfer pricing elsewhere, to avoid double taxation or mismatches. As the election is irrevocable once made for a given asset, the decision to opt in deserves careful upfront modelling.
Jérémie Mancel-Cottrel, Partner